Overview

Efficacy and Safety Study of Intra-articular Multiple Doses of Icatibant in Patients With Painful Knee Osteoarthritis

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The primary objective is to compare the overall treatment effect on pain relief between icatibant and placebo. The secondary objectives are to assess the efficacy of icatibant in term of onset, extent and duration of pain relief relative to triamcinolone, to evaluate the safety of icatibant, to evaluate overall conditions of daily life after treatment with icatibant, to assess systemic exposure of icatibant following intra-articular injection.
Phase:
Phase 2
Details
Lead Sponsor:
Sanofi
Treatments:
Bradykinin
Icatibant